Japanese and Taiwanese shares recovered on Monday after last week’s AI-driven sell-off, but South Korea’s reversal highlighted fragile investor confidence.
MOCKSVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only low nicotine tobacco company in the world, will host a webcast on Monday, November 16, 2026,
CHATTANOOGA, Tenn., Nov. 03, 2026 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) (the “Company”) announced that Linda Knoll notified the Company’s board of directors (the “Board”) of her intention to resign
CINCINNATI, Nov. 03, 2026 (GLOBE NEWSWIRE) — Executives from The E.W. Scripps Company (NASDAQ: SSP) will discuss the company’s business strategies at three investor conferences in November and December. Bank of America
PASCAGOULA, Miss., Nov. 03, 2026 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division completed a successful builder’s sea trials Saturday for the first Flight II ship in the San Antonio-class amphibious transport
Enhanced convenience and nationwide fulfillment support SenesTech’s growing ecommerce business SURPRISE, Ariz., Nov. 03, 2026 (GLOBE NEWSWIRE) — SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent birth control, today announced that its
Index rises to 146 as sales increase +2.3% year over year and +0.3% month over month MILWAUKEE, Nov. 03, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of
Brand-new product line up, 11:30AM Press Conference, visitor giveaways, Fat Fender Garage F-100 and TJ Hunt Aston Martin Vantage GT3 among highlights of Meguiar’s SEMA 2026 Booth # 22357 in Central Hall
MIDLAND, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) — New Era Energy & Digital, Inc. (Nasdaq: NUAI) (“New Era” or the “Company”), a developer of next-generation digital infrastructure and integrated power assets, today
MCLEAN, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted its 2027 funding calendar, which provides optional announcement dates for Reference Notes® securities and announcement dates for Reference
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today
Follow